{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:13:04Z","timestamp":1774458784205,"version":"3.50.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/spc.0000000000000012","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T12:58:07Z","timestamp":1382360287000},"page":"368-375","source":"Crossref","is-referenced-by-count":26,"title":["Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment"],"prefix":"10.1097","volume":"7","author":[{"given":"Sumbul","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-an","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20211004","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1210\/endo-106-3-663","article-title":"Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro.","volume":"106","author":"Bowers","year":"1980","journal-title":"Endocrinology"},{"key":"R2-7-20211004","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.273.5277.974","article-title":"A receptor in pituitary and hypothalamus that functions in growth hormone release.","volume":"273","author":"Howard","year":"1996","journal-title":"Science"},{"key":"R3-7-20211004","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/en.2006-0782","article-title":"Ghrelin and growth hormone secretagogue receptor expression in mice during aging.","volume":"148","author":"Sun","year":"2007","journal-title":"Endocrinology"},{"key":"R4-7-20211004","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach.","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"R5-7-20211004","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","article-title":"The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.","volume":"87","author":"Gnanapavan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-7-20211004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/B978-0-12-410473-0.00003-9","article-title":"The role of ghrelin in anorexia-cachexia syndromes.","volume":"92","author":"Guillory","year":"2013","journal-title":"Vitam Horm"},{"key":"R7-7-20211004","first-page":"611","article-title":"Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice.","volume":"123","author":"Porporato","year":"2013","journal-title":"J Clin Invest"},{"key":"R8-7-20211004","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1083\/jcb.200207165","article-title":"Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK12 and PI 3-kinaseAKT.","volume":"159","author":"Baldanzi","year":"2002","journal-title":"J Cell Biol"},{"key":"R9-7-20211004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus.","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R10-7-20211004","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/endo.141.11.7873","article-title":"The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion.","volume":"141","author":"Wren","year":"2000","journal-title":"Endocrinology"},{"key":"R11-7-20211004","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","article-title":"Ghrelin enhances appetite and increases food intake in humans.","volume":"86","author":"Wren","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-7-20211004","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ijo.0803001","article-title":"Ghrelin increases food intake in obese as well as lean subjects.","volume":"29","author":"Druce","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"R13-7-20211004","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tem.2005.09.004","article-title":"Developments in ghrelin biology and potential clinical relevance.","volume":"16","author":"Smith","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"R14-7-20211004","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/gast.2001.22158","article-title":"Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin.","volume":"120","author":"Asakawa","year":"2001","journal-title":"Gastroenterology"},{"key":"R15-7-20211004","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mce.2011.02.017","article-title":"The role of the central ghrelin system in reward from food and chemical drugs.","volume":"340","author":"Dickson","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"R16-7-20211004","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1002\/cncr.27430","article-title":"Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study.","volume":"118","author":"Hiura","year":"2012","journal-title":"Cancer"},{"key":"R17-7-20211004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3940(03)00789-4","article-title":"Centrally administered ghrelin suppresses sympathetic nerve activity in brown adipose tissue of rats.","volume":"349","author":"Yasuda","year":"2003","journal-title":"Neurosci Lett"},{"key":"R18-7-20211004","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1210\/jc.2004-1788","article-title":"Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.","volume":"90","author":"Garcia","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-7-20211004","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjc.6601620","article-title":"Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids.","volume":"90","author":"Moses","year":"2004","journal-title":"Br J Cancer"},{"key":"R20-7-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cyto.2001.0898","article-title":"Brain cytokine production and action in anorexia and cachexia.","volume":"15","author":"Plata-Salaman","year":"2001","journal-title":"Cytokine"},{"key":"R21-7-20211004","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2008060628","article-title":"IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting.","volume":"20","author":"Zhang","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R22-7-20211004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cyto.2011.10.008","article-title":"Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors.","volume":"57","author":"Batista","year":"2012","journal-title":"Cytokine"},{"key":"R23-7-20211004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI200421134","article-title":"Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells.","volume":"114","author":"Dixit","year":"2004","journal-title":"J Clin Invest"},{"key":"R24-7-20211004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ghir.2008.12.001","article-title":"Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system.","volume":"19","author":"Hattori","year":"2009","journal-title":"Growth Horm IGF Res"},{"key":"R25-7-20211004","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0896-6273(03)00063-1","article-title":"The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.","volume":"37","author":"Cowley","year":"2003","journal-title":"Neuron"},{"key":"R26-7-20211004","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1210\/en.2013-1179","article-title":"Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in MALE mice.","volume":"154","author":"Garcia","year":"2013","journal-title":"Endocrinology"},{"key":"R27-7-20211004","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","article-title":"Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia.","volume":"148","author":"DeBoer","year":"2007","journal-title":"Endocrinology"},{"key":"R28-7-20211004","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/en.2011-1217","article-title":"Differential effects of growth hormone versus insulin-like growth factor-I on the mouse plasma proteome.","volume":"152","author":"Ding","year":"2011","journal-title":"Endocrinology"},{"key":"R29-7-20211004","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.","volume":"30","author":"Moller","year":"2009","journal-title":"Endocr Rev"},{"key":"R30-7-20211004","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/bjp.2008.153","article-title":"Regulation of muscle mass by growth hormone and IGF-I.","volume":"154","author":"Velloso","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R31-7-20211004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ghir.2008.12.003","article-title":"Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.","volume":"19","author":"Garcia","year":"2009","journal-title":"Growth Horm IGF Res"},{"key":"R32-7-20211004","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1500447","article-title":"Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects.","volume":"150","author":"Akamizu","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R33-7-20211004","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/jc.2007-2018","article-title":"Acute effects of ghrelin administration on glucose and lipid metabolism.","volume":"93","author":"Vestergaard","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-7-20211004","first-page":"320","article-title":"MK-0677, an orally active growth hormone secretagogue reverses diet-induced catabolism.","volume":"83","author":"Murphy","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-7-20211004","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-149-9-200811040-00003","article-title":"Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.","volume":"149","author":"Nass","year":"2008","journal-title":"Ann Intern Med"},{"key":"R36-7-20211004","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1210\/jc.2008-0632","article-title":"Effects of an oral growth hormone secretagogue in older adults.","volume":"94","author":"White","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-7-20211004","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.12-5-594","article-title":"Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers.","volume":"12","author":"Garcia","year":"2007","journal-title":"Oncologist"},{"key":"R38-7-20211004","doi-asserted-by":"crossref","first-page":"RC26","DOI":"10.1007\/BF03345096","article-title":"EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man.","volume":"25","author":"Broglio","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"R39-7-20211004","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/jc.2006-2160","article-title":"Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects.","volume":"92","author":"Piccoli","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-7-20211004","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2003-031768","article-title":"Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial.","volume":"89","author":"Neary","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-7-20211004","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","article-title":"Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexiacachexia: a randomised, placebo-controlled, double-blind, double-crossover study.","volume":"98","author":"Strasser","year":"2008","journal-title":"Br J Cancer"},{"key":"R42-7-20211004","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/cncr.24917","article-title":"Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study.","volume":"116","author":"Lundholm","year":"2010","journal-title":"Cancer"},{"key":"R43-7-20211004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","article-title":"Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study.","volume":"21","author":"Garcia","year":"2013","journal-title":"Support Care Cancer"},{"key":"R44-7-20211004","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1677\/joe.0.1650139","article-title":"Specific binding sites for synthetic growth hormone secretagogues in nontumoral and neoplastic human thyroid tissue.","volume":"165","author":"Cassoni","year":"2000","journal-title":"J Endocrinol"},{"key":"R45-7-20211004","first-page":"1738","article-title":"Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines.","volume":"86","author":"Cassoni","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-7-20211004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-291X(02)03028-0","article-title":"Anticachectic effect of ghrelin in nude mice bearing human melanoma cells.","volume":"301","author":"Hanada","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R47-7-20211004","first-page":"1393","article-title":"Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia.","volume":"28","author":"Wang","year":"2006","journal-title":"Int J Oncol"},{"key":"R48-7-20211004","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00535-009-0166-z","article-title":"The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice.","volume":"45","author":"Matsumura","year":"2010","journal-title":"J Gastroenterol"},{"key":"R49-7-20211004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-0-12-381272-8.00021-0","article-title":"Rikkunshito as a ghrelin enhancer.","volume":"514","author":"Takeda","year":"2012","journal-title":"Methods Enzymol"},{"key":"R50-7-20211004","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1038\/tp.2011.25","article-title":"Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.","volume":"1","author":"Fujitsuka","year":"2011","journal-title":"Translat Psychiatr"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201312000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T08:40:23Z","timestamp":1633509623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201312000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000012","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}